ChemoCentryx is a biopharmaceutical company focused on the development and commercialization of new medications targeting inflammatory disorders, autoimmune diseases, and cancer. The Company commenced operations in 1997. ChemoCentryx’s lead drug candidate is avacopan, which the Company describes as “a potential first-in-class, orally-administered molecule that employs a novel for the treatment of patients with ANCA vasculitis.

Volkswagen is a large international producer of passenger vehicles.

Apex Clearing Corporation and Interactive Brokers, LLC are brokerage firms regulated by the Financial Industry Regulatory Authority, Inc.

Pinterest operates a platform that purports to provide inspiration for its users’ lives. Monthly active users (“MAUs”) are the number of Pinterest users who interact with Pinterest at least once during the 30-day period ending on the date of measurement.

Peloton provides interactive fitness products such as the Peloton Bike and the Peloton Tread+ and Tread, which include touchscreens that stream live and on-demand classes. Peloton also provides connected fitness subscriptions and access to all live and on-demand classes.

Boingo Wireless, Inc. provides wireless internet connectivity solutions for consumer devices.On February 26, 2021, Boingo entered into an Agreement and Plan of Merger (the “Merger Agreement”), pursuant to which Boingo will be acquired by an affiliate of Digital Colony Management, LLC. Under the terms of the Merger Agreement, the Company’s shareholders will receive $14.00 in exchange for each share of Boingo common stock they own. On March 1, 2021, Boingo issued a press release announcing the Proposed Merger.

Verus International, Inc. purports to be an international supplier of consumer food products, focused on international consumer packaged goods, foodstuff distribution and wholesale trade.

Arcimoto Inc. is purportedly engaged in the business of manufacturing ultraefficient three-wheeled electric vehicles.

Acadia Pharmaceuticals Inc. is a biopharmaceutical company that focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The Company is developing pimavanserin as a treatment for dementia-related psychosis and as an adjunctive treatment for schizophrenia, as well as an adjunctive treatment for major depressive disorder. In June 2020, Acadia submitted a supplemental New Drug Application ("sNDA") with the FDA to expand pimavanserin's label to include treatment for dementia-related psychosis.

Emergent BioSolutions Inc. provides a variety of products and solutions that address public health threats, including manufacturing for the development of new vaccines. In April 2020, during the initial months of the COVID-19 pandemic, Emergent entered an agreement with J&J to provide its Bayview manufacturing facilities to support J&J’s goal of supplying one billion doses of a COVID-19 vaccine. Under the deal, valued at $135 million, Emergent would provide drug substance manufacturing services and reserve large-scale manufacturing capacity for J&J.

Churchill Capital Corporation IV is a blank check company, also known as a special purpose acquisition company (“SPAC”).  On Monday, February 22, 2021, a merger agreement between Churchill Capital Corporation IV ("CCIV") and Lucid Motors was announced. CCIV’s and Lucid’s transaction equity value was estimated at $11.75 billion. Details of the merger disclosed that Lucid was projecting the production of only 557 vehicles in 2021, instead of the 6,000 it had allegedly been touting in the run-up to the merger announcement.

LifeMD, Inc. is a direct-to-patient telehealth company. It offers a telemedicine platform that purports to help patients access licensed providers for diagnoses, virtual care, and prescription medications. LifeMD was previously known as Conversion Labs, Inc., and its common stock traded on the NASDAQ exchange under the symbol “CVLB.” The Company’s name was changed effective February 19, 2021, and the stock symbol changed effective February 22, 2021.

On January 27, 2021, Perspecta announced its entry into an Agreement and Plan of Merger pursuant to which it would be sold to Veritas Capital.

Credit Suisse Group AG is a global financial services company.

Intrusion Inc. develops, sells, and supports products that purport to protect entities from cyberattacks by combining advanced threat intelligence with real-time artificial intelligence. It offers three products: Shield, a cybersecurity solution packaged as a comprehensive, real-time AIbased Security-as-a-Service; TraceCop, a big data tool with IP intelligence, including reputation information on known good and known bad active IP addresses; and Savant, a network monitoring solution that identifies suspicious traffic in real-time.

Franklin Wireless Corp. purports to be a leading provider of intelligent wireless solutions such as mobile hotspots, routers, trackers, and other devices.

On October 5, 2020, RMG Acquisition Corp. (“RMG”) announced a definitive agreement for a business combination with Romeo Power Inc. that would result in Romeo becoming a publicly listed company. On December 29, 2020, Romeo announced that it completed its business combination with RMG.

Canaan Inc. engages in the research, design, and sale of integrated circuit (“IC”) final system products by integrating IC products for bitcoin mining and related components primarily in the PRC.

Fibrogen, Inc. is a biopharmaceutical company that develops medicines for the treatment of anemia, fibrotic disease, and cancer. Its most advanced product is roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor-prolyl hydroxylase (“HIF-PH”) activity that acts by stimulating the body’s natural pathway for red cell production. In 2019, the Company filed its New Drug Application (“NDA”) with the U.S. Food and Drug Administration for the approval of roxadustat for the treatment of anemia due to chronic kidney disease (“CKD”).

Champignon Brands Inc. purports to be engaged in the formulation and manufacturing of novel ketamine, ketamine derivatives and other psychedelics, and delivery platforms for nutraceutical and psychedelic medicine while being supported by its psychedelic medicine clinic platform.